Eslam Samir

• Iris LLC is a leading Events, Exhibitions & Marketing Solutions organization at UAE established at 2018.
• Established relationships with key decision-makers within customer's organization to promote growth and retention.
• Identified and pursued valuable business opportunities to generate new company revenue and improve bottom line profit.
• Negotiated and closed long-term agreements with new clients in assigned territory.
• Generated new business with marketing initiatives and strategic plans.
• Developed new proposals, contracts and procedures to draw in more clients and streamline work operations.

• Responsible for Abu Dhabi district Mubadala-SEHA-Military and Private Sectors, Cardiovascular Unit
• Initiated strong long term value based partnership with main key accounts Cleveland Clinic, Imperial Collage Diabetes Center and Zayed Military Hospital.
• Built successful relations with main key customers and local societies boosting brand awareness and patient use for Repatha.
• Repatha market share increased from 55% end of 2019 to 75% by end 2021.

• Responsible for Eastern Province, Saudi Arabia General Medicine Line (Aranesp-Mimpara-Prolia) Private, MOH and Institution Sectors, managing business of 5.8 M$.
• Managing team of 3 senior product specialists supporting and guiding them to achieve agreed annual objective.
• Landed successful launch for Prolia at Eastern Province 2018 Ach: 122% Growth 42%.
• Trained and provided coaching to2 junior Saudi team members.
• Responsible for annual contract renewal for Al Dawa Pharmacy chain and Al Mana Hospital group.

• Responsible for special MOH project to enlist and maximise Aranesp usage at MOH hospitals at Al Giza - Al Sharkia - Al Fayoum.

• Worked closely with product development teams to create and maintain marketing materials for sales presentations and client meetings.
• Developed and implemented products awareness program (Amgen Nephrology educational & development Project).
• Edited and assembled training materials and reports to meet client requirements.
• We proudly achieved 9M$ budget achievement at 2014 (Amgen MEA Golden top performing country 2014).

• Landed successful launch for Amgen Nephrology Line Products Aranesp and Mimpara at Eastern Province Libya, managing 15 nephrology centers.
• Built strategic partnership with the Libyan Nephrology Society, main nephrology centers & patient societies.
• Recognized as Amgen MEA Platinum best performer at 2013 Ach 162%.

• Responsible for Eastern Province, Libya, AHT/Diabetes Line.
• Launching JANUVIA (sitagliptin) in Libya Eastern Province.
• Inclusion of JANUVIA at MOH annual Tender list.